Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Keymed Bio Secures $45M Payment as AstraZeneca Starts Phase III Cancer ...
China: Keymed Bio trades up after pricing HK IPO at top of marketed ...
Keymed Biosciences | LinkedIn
Keymed Biosciences - Crunchbase Company Profile & Funding
Keymed Biosciences' Kangyueda Approved for CRSwNP Treatment in China ...
Keymed Biosciences Announces 2025 Annual Results and Business Updates ...
KEYMED IMPORTADOR INSUMOS MEDICOS (@keymedecuador.insumosmedicos ...
KeyMed | LinkedIn
Home | KeyMED
Keymed Biosciences Reports Strong Annual Results and Promising Pipeline ...
Olympus Keymed Logo
How Keymed steered the China-to-US NewCo model in biotech
Keymed Biosciences Announces Approval of Stapokibart For the Treatment ...
Keymed Biosciences (2162HK) VRIO Analysis – DCFmodeling.com
Keymed Biosciences Announces Annual Results of 2024 - BioSpace
KeyMed ePrescribing - Independent Reviews, Comparisons, and More!
KeyMed by dr.Kobets - Крем-антиосксидант Derm Acte c витаминами С и E ...
Keymed Biosciences Announces Approval of IND for CM518D1 by the ...
Keymed Biosciences Enters Global Licensing Agreement with Platina ...
China's KeyMed, InnoCare Grant Prolium Bio Global Rights to Cancer Drug ...
Keymed | Key Medical Asia | Medical Supplies | Key Medical Asia | Singapore
Keymed Biosciences Announces 2025 Annual Results and Business Updates
KEYMED BIO-B Sells ~15% Stake in Ouro Medicines AASTOCKS Financial News ...
Anasayfa - Keymed Medikal
Sidley Represents Keymed Biosciences in US$1.1 Billion Partnership With ...
Key Medical - KeyMed Medical Pen Torch Light. Slim. Compact. Durable ...
Keymed – Pediatotem
KeyMed Partners Inc. | LinkedIn
KEYMED | LinkedIn
Keymed Biosciences Initiates CMG901 Phase III – AstraZeneca Triggers ...
PRP ACD keymed in vivo ™ Zestaw do pozyskania osocza boagtopłytkowego
Keymed Bioscience's CM310 for AD Treatment | PDF | Interleukin 4 | Allergy
KeyMed Partners - Crunchbase Company Profile & Funding
Excited to announce that KeyMed is a proud Friend sponsor of Axon, a ...
Keymed Biosciences Completes US$108 Million Top-up Placement – Global ...
Epirium Bio Announces Positive Type C (End-of-Phase 1) Meeting with FDA ...
InnoCare Pharma and KeyMed Partner with Prolium Bioscience for ...
KeyMed Ltd
AZD0901 / Keymed Biosciences, Lepu Med, AstraZeneca
KEYMED BIO-B Receives USD45M Milestone Payment for CMG901 License ...
Keymed Biosciences Secures IND Approval for Promising Cancer Treatment ...
Newco Prolium licenses antibody from Innocare, Keymed for $520M | BioWorld
Baza wiedzy - Medycyna Estetyczna - Keymed Polska
Keymed Biosciences Licenses CM313 to Timberlyne Therapeutics for Global ...
KEYMED | Bangkok
Keymed Biosciences' drug approved by NMPA for atopic dermatitis ...
KeyMed Devices - Crunchbase Company Profile & Funding
Keymed Biosciences Presents CM336 Data for Relapsed Multiple Myeloma at ...
Octagon Capital
康诺亚-B简介-康诺亚-B成立时间|总部|股票代码-排行榜123网
Top 60 Medical Equipment Companies in Turkey (2025) | ensun
康诺亚
Home - GBMSA
$康诺亚-B(02162)$ 国内首个治疗慢性鼻窦炎伴鼻息肉生物制剂康悦达®（司普奇拜单抗）获批上市Keymed Bio... - 雪球
Úvodná stránka | keymed.sk
Про нас - Косметолічний центр Тетяни Кобець
U.S.-China Drugs Tie-ups Come Under Threat - The Wire China
2162 Stock Price and Chart — HKEX:2162 — TradingView
